HHS, DOD invest to expand U.S. COVID-19 test production
The departments of Health and Human Services and Defense this weekend announced a pair of contracts to expand domestic COVID-19 testing capacity. HHS and DOD to Hologic, Inc. $119 million to expand the supplier’s production capacity for COVID-19 tests made at facilities in Wisconsin, Maine and California.
The funds are expected to increase Hologic’s production capacity to 13 million tests per month by January 2022.
The agencies a $12.7 million contract with InBios International, Inc., to expand production of two rapid point-of-care SARS-CoV-2 tests. The funds will enable InBios to reach a production capacity of 400,000 units per week by May 2021.
Related News Articles
Headline
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…